We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.50 | 1.40 | 1.60 | 1.50 | 1.50 | 1.50 | 195,426 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.29 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2020 08:08 | Fill ya boots lads.... | hodhasharon | |
31/7/2020 08:08 | You will have 1000 shares then will you | albert3591 | |
31/7/2020 08:08 | I said disgraceful. Undisclosed fee rns is what i ssis theyd announced all along. Why talk in riddles when you cpuld have nust done pyc revenue multiplied by 20% = peanuts | spacedust | |
31/7/2020 08:07 | As usual the markets missing the point. Any more and I'll be doubling up | 7rademark | |
31/7/2020 08:06 | Great rns was it. | albert3591 | |
31/7/2020 08:04 | Or maybe not!!! | albert3591 | |
31/7/2020 08:02 | Looks like you boys are going to have a good day,good luck. | albert3591 | |
31/7/2020 08:01 | Disgraceful rns | spacedust | |
31/7/2020 07:54 | It would have been nice if it was 20% of Astellas last full year's total income. | bidmsa | |
31/7/2020 07:50 | Wow, employment till Xmas!! | faz | |
31/7/2020 07:42 | Usually cost we do in similar projects is around £1000/day so if 2 resources takes 5 months to complete then it should be around 200k ,since its first big contract so may be negotiated around 150k .This contract will transform the company | tmmalik | |
31/7/2020 07:37 | Welcome to the Premier league pyc.Eyes of the world on you now. It's not about money or the size of the contract this is about being trusted by a major, how many times does that happen to tiny mcaps. Usually never.Pyc are going to be massive. That much is clear. | 7rademark | |
31/7/2020 07:36 | Wow a whole £180k in revenue!!! | faz | |
31/7/2020 07:31 | Albert is a legend | stg8123 | |
31/7/2020 07:27 | The key here is that the value of the contract is for initial work on only one asset. Big players in Oncology like Astellas (market cap 3tn yen, £20bn) can have R&D pipelines of 50 or more assets in some cases Consider also how high the margin on each incremental contract of this nature will be and the impact on the bottom line. | photon | |
31/7/2020 07:26 | So contract worth about £160k. Lot more than 35k that some were talking about. | owenga | |
31/7/2020 07:23 | 30p today anyone? Wot No Albert? | hodhasharon | |
31/7/2020 07:20 | Here you go ,it's just start ,more to follow . | tmmalik | |
31/7/2020 07:17 | Don't forget the market cap of this company is <£9m so plenty of scope to multibag on good news from here! | bountyhunter | |
31/7/2020 07:15 | 20% of last year's income is a significant win, they've already flagged it's around that size so it's good news that it's finally been finalised :) A Japanese company as well so all good publicity. | bountyhunter | |
31/7/2020 07:14 | contract rns in | carlisle44 | |
31/7/2020 07:11 | the Big contract news hoped for is rather a disappointment! | hickersp |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions